Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of polymyxin B, bacitracin, and lidocaine is a topical antibiotic medication with pain relief properties. It's commonly used to prevent infections in minor skin injuries such as cuts, scrapes, and burns[1][2]. This medication is available over-the-counter in the United States[7]. ## Composition and Mechanism This combination contains three antibiotics (polymyxin B, bacitracin, and neomycin) plus lidocaine, which provides pain relief[1][3]. Each component has a specific function: - **Bacitracin**: Prevents formation of bacterial protective covering essential for bacterial survival[5] - **Lidocaine**: Acts as a local anesthetic by blocking pain signals from nerves to brain, decreasing pain sensation and skin irritation[5] - **Polymyxin B**: Kills bacteria by destroying the bacterial cell membrane[5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bacitracin + Lidocaine + Polymyxin B.